EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Sodium Butyrate Inhibits the Expression of Thymidylate Synthase and Induces Cell Death in Colorectal Cancer Cells

Nayeon Kim, Changwon Yang iD

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms25031572 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nayeon Kim und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Science Education, Ewha Womans University, Seoul 03760, Republic of Korea. Hauptthemen laut MEDLINE: Thymidylate Synthase, Colorectal Neoplasms. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Education.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The most commonly used chemotherapy for colorectal cancer (CRC) is the application of 5-fluorouracil (5-FU). Inhibition of thymidylate synthase (TYMS) expression appears to be a promising strategy to overcome the decreased sensitivity to 5-FU caused by high expression of TYMS, which can be induced by 5-FU treatment. Several compounds have been shown to potentially inhibit the expression of TYMS, but it is unclear whether short-chain fatty acids (SCFAs), which are naturally produced by bacteria in the human intestine, can regulate the expression of TYMS. Sodium butyrate (NaB) is the most widely known SCFA for its beneficial effects. Therefore, we investigated the enhancing effects on inhibition of cell viability and induction of apoptosis after co-treatment of NaB with 5-FU in two CRC cell lines, HCT116 and LoVo. This study suggests that the effect of NaB in improving therapeutic sensitivity to 5-FU in CRC cells may result from a mechanism that strongly inhibits the expression of TYMS. This study also shows that NaB inhibits the migration of CRC cells and can cause cell cycle arrest in the G2/M phase. These results suggest that NaB could be developed as a potential therapeutic adjuvant to improve the therapeutic effect of 5-FU in CRC.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Thymidylate SynthaseColorectal NeoplasmsHumansButyric AcidDrug Resistance, NeoplasmFluorouracilApoptosis

Stichwörter der Autor:innen

apoptosiscolorectal cancershort-chain fatty acidssodium butyratethymidylate synthase

Substanzen

Butyric AcidThymidylate SynthaseFluorouracil

Autor:innen und Institutionen

  • Department of Science Education, Ewha Womans University, Seoul 03760, Republic of Korea.

ORCID-Profile: Changwon Yang

Förderung

  • Ministry of Education

Zitieren

APA

Kim, N., & Yang, C. (2024). Sodium Butyrate Inhibits the Expression of Thymidylate Synthase and Induces Cell Death in Colorectal Cancer Cells. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25031572

Vancouver

Kim N, Yang C. Sodium Butyrate Inhibits the Expression of Thymidylate Synthase and Induces Cell Death in Colorectal Cancer Cells. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25031572

BibTeX
@article{Kim2024,
  author = {Kim, Nayeon and Yang, Changwon},
  title = {Sodium Butyrate Inhibits the Expression of Thymidylate Synthase and Induces Cell Death in Colorectal Cancer Cells},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms25031572}
}
Kostenlos starten →